Beam Therapeutics BEAM Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Beam Therapeutics’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's interest paid?
- Beam Therapeutics (BEAM) reported interest paid of $0 in Q4 2025.
- What is the long-term trend for Beam Therapeutics's interest paid?
- Over 4 years (2021 to 2025), Beam Therapeutics's interest paid has grown at a -100.0% compound annual growth rate (CAGR), from $567K to $0.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.